Affymetrix
This article was originally published in The Gray Sheet
Executive Summary
Genetic MicroSystems will operate as a wholly owned facility of Affymetrix following the completion of an acquisition agreement valued at roughly $101 mil. and announced Sept. 13 (1"The Gray Sheet" Sept. 20, p. 20)
You may also be interested in...
Affymetrix
Acquisition of privately held DNA array technology firm Genetic MicroSystems for 1 mil. shares of common stock valued at about $101 mil. is outlined in a definitive agreement announced Sept. 13. The Woburn, Massachusetts based firm's product line, which includes the GMS 417 arrayer and GMS 418 array scanner, will complement Affymetrix' high-volume GeneChip platform. The deal is expected to close in Jan. 2000. Separately, the U.S. Patent and Trademark Office Board of Patent Appeals and Interferences rules in favor of Affymetrix in patent interference proceedings with Palo Alto, California-based Incyte Pharmaceuticals. The board's decision, which Incyte intends to appeal, says that Incyte did not provide sufficient evidence that Affymetrix' claims were not supported by written description or enablement
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.
Over The Counter 2 Apr 2024: Analyzing The Spin-Out Trend In Consumer Health, With HBW’s Malcolm Spicer And Tom Gallen
In this episode, HBW Insight’s Europe and US editors bring their expertise to bear on the current the trend towards standalone OTC companies in global consumer health. We look at four major players: Haleon, which separated from GSK almost two years ago; Kenvue, soon to celebrate its first anniversary as a new company; Sanofi Consumer Healthcare, which is poised to split from its pharma parent; and Bayer, which has decided to buck the trend, holding on to its consumer health division. We discuss some of the advantages of becoming a standalone company, for example in leaning into a wider concept of self-care.